Skip to main content

Your search for “covid-19” returned 609 results

A Nanomaterial Path Forward for COVID-19 Vaccine Development

July 15, 2020

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.

Rady School of Management at UC San Diego Launches COVID-19 Business Recovery Coalition

May 14, 2020

The Rady School of Management at the University of California San Diego has launched the Rady School Business Recovery Coalition to help businesses in the San Diego region navigate the unprecedented challenges faced by COVID-19.

COVID-19 Experts Directory

April 7, 2020

Experts at UC San Diego are available to discuss the novel coronavirus, the COVID-19 illness and the societal impacts of the pandemic.

UC San Diego Joins Second Major National Clinical Trial for Novel Coronavirus

September 2, 2020

UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.

In Wake of COVID-19 Pandemic, a Crashing Wave of Neuropsychiatric Problems?

April 14, 2020

Researchers suggest that in the aftermath of the novel coronavirus pandemic, a host of neuropsychiatric challenges may remain — or emerge — for those recovering from COVID-19 infections.

For Transplant Patients, COVID-19 Vaccination Presents a Different Uncertainty

July 1, 2021

Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney.

Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?

July 9, 2020

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.

SDSC Researchers Develop Potential COVID-19 Protease Inhibitors

April 15, 2020

UC San Diego researchers recently created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs that identifies 64 compounds as potential inhibitors of the COVID-19 protease.

Fighting COVID-19 with Knowledge Graphs

June 1, 2020

The National Science Foundation awards two SDSC researchers funding to organize COVID-19 information into a knowledge network that integrates health, pathogen, and environmental data to track cases across greater San Diego.

UC San Diego Health Supports Statewide Rollout of CA Notify Exposure Notification System

December 7, 2020

The California governor’s office today announced a statewide expansion to make CA Notify available to all Californians starting Thursday, December 10 in partnership with UC San Diego Health.

Category navigation with Social links